 |
|
|
| |
Ledipasvir/Sofosbuvir for 12 Weeks Is Safe and Effective in Adolescents With
Chronic Hepatitis C Virus Infection and Hematologic Malignancies Undergoing Chemotherapy
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Manal Hamdy El-Sayed,1 Fatma S. Elsayed Ebeid,1 Abdel-Rahman Zekri,2 Benedetta Massetto,3 Kathryn Kersey,3 Anu Osinusi,3 Fangqiu Zhang,3 Diana M. Brainard,3 Walaa Elsayed,2 Alaa El-Haddad2
1Children's Hospital, Ain Shams University, Cairo, Egypt; 2National Cancer Institute-Cairo, Cairo University, Cairo, Egypt; 3Gilead Sciences, Inc., Foster City, California, USA
References
1. The DHS Program. Egypt Health Issues Survey 2015: https://dhsprogram.com/pubs/pdf/FR313/FR313.pdf; 2. Said Z, et al. Liver Int 2009;29:518-24; 3. El-Ashry R, et al. Med Oncol 2013:30:559; 4. Harvoni
[package insert]. Foster City, CA: Gilead Sciences, Inc., Apr 2017; 5. Pui CH, et al. Ann Hematol 2004;83:S124-6; 6. Pui CH, et al. N Engl J Med 2009;360: 2730-41; 7. Pui CH, et al. Blood 2004;104:2690-6.
|
| |
|
|
|
|
|
